We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Researchers Explore Why Certain Immunotherapy Patients Develop Lung Inflammation

News   Sep 05, 2019 | Original story from Johns Hopkins Medicine

 
Researchers Explore Why Certain Immunotherapy Patients Develop Lung Inflammation

Credit: Pixabay

 
 
 

RELATED ARTICLES

Criteria for Cancer Clinical Trials Might Be Too Strict

News

Federal regulations may be keeping lung cancer patients out of clinical trials simply because the patients are on medications that might affect the electrical system of the heart. The regulations may be preventing al proportion of patients from participating in clinical trials.

READ MORE

30% of Patients Taking Opioids Face Adverse Drug Interactions

News

Patients who do not disclose use of other medications are at an increased risk of adverse drug interactions and addiction, according to a new study. The authors estimate that approximately 30% of patients experience such interactions; however, very few are detected and reported.

READ MORE

Trial Suggests Immunotherapy Is Superior to Chemotherapy in Some Children With Relapsed Leukemia

News

New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE